News
Issue of Equity
20 December 2012
TyraTech, Inc. (AIM: TYR), a natural life sciences company, announces that it has issued 419,050 new common shares of $0.001 each in the capital of the Company (the "New Common Shares") in consideration for US$25,000 in services provided to the Company by a third-party consultant. The number of common shares issued was determined using the mid-market closing price on the date of the consulting agreement.
Application has been made to the London Stock Exchange for the New Common Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission and the commencement of dealings will take place on 27 December 2012.
Following Admission, the Company will have 108,195,055 common shares of $0.001 each in issue. The number of restricted common shares trading under TIDM 'TYR' following Admission will be 80,908,686 and the number of unrestricted common shares trading under TIDM 'TYRU' following Admission will continue to be 27,286,369.
In addition, the Company holds 1,084,413 common shares in treasury.
For further information please contact:
TyraTech Inc.
Alan Reade, Executive Chairman
Tel: +1 919 415 4310
Peter Jerome, Chief Financial Officer
Tel: +1 919 415 4280
N+1 Singer, Nominated Adviser and Joint Broker
Aubrey Powell / Alex Wright
Tel: +44 20 3205 7500
First Columbus LLP, Joint Broker
Chris Crawford
Tel: +44 20 3002 2070
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.